MetLife: S&P Intraday Laggard

NEW YORK ( TheStreet) -- Metlife ( MET) was the worst performer in the S&P 500 intraday Wednesday.

The S&P 500 rose 2.18 points, or 0.16%, to 1,398.13, in trading Wednesday morning.

Shares of MetLife fell 4.38% to $37.73. The Federal Reserve rejected MetLife's capital plan on Tuesday.

MetLife CEO Steven Kandarian said he is "deeply disappointed with the Federal Reserve's announcement," and didn't "believe that the bank-centric methodologies used under the CCAR are appropriate for insurance companies, which operate under a different business model than banks."

MetLife has an estimated price-to-earnings ratio for next year of 6.74 times; the average for life insurance companies is 11.32. For comparison, Aflac ( AFL) has a lower forward P/E of 6.53.

Eighteen of the 23 analysts who cover Metlife rated it buy; five analysts gave the stock a hold rating.

TheStreet Ratings gives Metlife a B grade with a buy rating and a $43.99 price target. The stock has risen 21.04% year to date.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

-- Written by Alexandra Zendrian

>To contact the writer of this article, click here: Alexandra Zendrian

>To submit a news tip, send an email to:

>To follow the writer on Twitter, go to Alexandra Zendrian.